[Form 3] UTAH MEDICAL PRODUCTS INC Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Utah Medical Products Inc. director Kevin Timken reported an initial beneficial ownership position that includes a stock option to buy 10,000 shares of the company’s common stock. The option has an exercise price of $58.10 per share, becomes exercisable on 10/01/2026, and expires on 10/31/2035.

The option vests 25% on 10/01/2026, with an additional 6.25% vesting on 01/01/2027 and on the first day of each calendar quarter thereafter, becoming fully exercisable on 10/01/2029. This filing reflects his status as a director and provides transparency into his equity-based compensation.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Timken Kevin

(Last) (First) (Middle)

7043 S 300 W

(Street)

MIDVALE UT 84047

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/31/2025

3. Issuer Name and Ticker or Trading Symbol
UTAH MEDICAL PRODUCTS INC [ UTMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option - Right to Buy	10/01/2026(1)	10/31/2035	Common Stock	10,000	$58.1	D

Explanation of Responses:

1. Option vests 25% on 10/01/2026 and 6.25% on 01/01/2027 and the first day of each calendar quarter thereafter. Fully exercisable on 10/01/2029.

	/s/Kevin Timken	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.